(Total Views: 455)
Posted On: 10/16/2022 4:56:12 PM
Post# of 149002
Re: KenChowder #129418
As long as one of the holds is on Covid I feel we should stay current because the safety info would come from CD10, CD12 and Long Haulers and everything with Amarex and if there is Covid hold release it is possible that HIV partial would be released.
Plus, and maybe this is just me, but after the last two and half years, I feel there is a whole layer of s**t under the surface of everything that we may need to be aware of to be successful in our current "goodie two shoes" approach to the FDA. Just the last little run up too 1.26 and we saw the fake law suits and attacks come back. NVAX was held off the market for two years and then given an approval; the stock was $76 before approval, it's now $19. It is being hammered on the back side of approval.
Keep LH out of sight on a back burner is smart.
Plus, and maybe this is just me, but after the last two and half years, I feel there is a whole layer of s**t under the surface of everything that we may need to be aware of to be successful in our current "goodie two shoes" approach to the FDA. Just the last little run up too 1.26 and we saw the fake law suits and attacks come back. NVAX was held off the market for two years and then given an approval; the stock was $76 before approval, it's now $19. It is being hammered on the back side of approval.
Keep LH out of sight on a back burner is smart.
(2)
(0)Scroll down for more posts ▼
